{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["18(11)"],"submitter":["Palugulla S"],"pubmed_abstract":["Oxaliplatin is a platinum drug active against digestive tract cancers. Among its side effects, peripheral neuropathy"],"journal":["Asian Pacific journal of cancer prevention : APJCP"],"pagination":["3157-3165"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC5773806"],"repository":["biostudies-literature"],"pubmed_title":["Association of Voltage-Gated Sodium Channel Genetic Polymorphisms with Oxaliplatin-Induced Chronic Peripheral Neuropathy in South Indian Cancer Patients"],"pmcid":["PMC5773806"],"pubmed_authors":["Narayan SK","Kayal S","Dkhar SA","Thakkar DN","Palugulla S"],"additional_accession":[]},"is_claimable":false,"name":"Association of Voltage-Gated Sodium Channel Genetic Polymorphisms with Oxaliplatin-Induced Chronic Peripheral Neuropathy in South Indian Cancer Patients","description":"Oxaliplatin is a platinum drug active against digestive tract cancers. Among its side effects, peripheral neuropathy","dates":{"release":"2017-01-01T00:00:00Z","publication":"2017 Nov","modification":"2025-04-29T10:03:13.974Z","creation":"2025-04-06T19:21:31.995Z"},"accession":"S-EPMC5773806","cross_references":{"pubmed":["29172294"],"doi":["10.22034/APJCP.2017.18.11.3157"]}}